<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
      <journal-title-group>
        <journal-title>Febs Letters</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0014-5793</issn>
      <issn pub-type="epub">1873-3468</issn>
      <publisher>
        <publisher-name>Elsevier Science B.V</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3149668</article-id>
      <article-id pub-id-type="pmid">21723865</article-id>
      <article-id pub-id-type="publisher-id">FEBS34800</article-id>
      <article-id pub-id-type="doi">10.1016/j.febslet.2011.06.019</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Sost</italic> down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Galea</surname>
            <given-names>Gabriel L.</given-names>
          </name>
          <email>gabriel.galea@bristol.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sunters</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meakin</surname>
            <given-names>Lee B.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zaman</surname>
            <given-names>Gul</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sugiyama</surname>
            <given-names>Toshihiro</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lanyon</surname>
            <given-names>Lance E.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Price</surname>
            <given-names>Joanna S.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>School of Veterinary Sciences, University of Bristol, Bristol BS40 5DU, United Kingdom</aff>
      <aff id="aff2"><label>b</label>Department of Veterinary Basic Sciences, The Royal Veterinary College, University of London, London NW1 0TU, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author at: School of Veterinary Sciences, University of Bristol, Bristol BS40 5DU, United Kingdom. <email>gabriel.galea@bristol.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>04</day>
        <month>8</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>04</day>
        <month>8</month>
        <year>2011</year>
      </pub-date>
      <volume>585</volume>
      <issue>15</issue>
      <fpage>2450</fpage>
      <lpage>2454</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>2</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>6</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier B.V.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Federation of European Biochemical Societies</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>► <italic>Sost</italic> down-regulation is stimulated by mechanical strain in osteoblastic cells. ► <italic>Sost</italic>/Osteocalcin regulation by strain in Saos2 osteoblastic cells requires Cox2. ► PGE2-mediated <italic>Sost</italic> regulation by strain in Saos2 cells requires EP4/ERK signaling. ► Osteocalcin regulation by strain in Saos2 cells requires EP2/PKC signaling.</p>
      </abstract>
      <abstract>
        <p>Sclerostin is a potent inhibitor of bone formation which is down-regulated by mechanical loading. To investigate the mechanisms involved we subjected Saos2 human osteoblastic cells to short periods of dynamic strain and used quantitative reverse transcriptase polymerase chain reaction to compare their responses to unstrained controls. Strain-induced <italic>Sost</italic> down-regulation was recapitulated by cyclo-oxygenase-2-mediated PGE2, acting through the EP4 receptor, whereas strain-related up-regulation of osteocalcin was mediated by the EP2 receptor. Strain-related <italic>Sost</italic> regulation required extracellular signal-regulated kinase signaling, whereas osteocalcin required protein kinase C. These findings indicate early divergence in the signaling pathways stimulated by strain and establish PGE2/EP4 as the pathway used by strain to regulate <italic>Sost</italic> expression.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>PTH, parathyroid hormone</kwd>
        <kwd>BMP, bone morphogenetic protein</kwd>
        <kwd>Cox, cyclo-oxygenase</kwd>
        <kwd>PG, prostaglandin</kwd>
        <kwd>TCS, TCS2510</kwd>
        <kwd>qRT-PCR, quantitative reverse transcriptase polymerase chain reaction</kwd>
        <kwd>PKA, protein kinase A</kwd>
        <kwd>PKC, protein kinase C</kwd>
        <kwd>ERK, extracellular signal-regulated kinase</kwd>
        <kwd>MAPK, mitogen activated protein kinase</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Sclerostin</kwd>
        <kwd>PGE2 signaling</kwd>
        <kwd>Mechanical strain</kwd>
        <kwd>Osteoporosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>The natural functional regulator of bone architecture is habitual mechanical loading. Age- and estrogen deficiency-related failure of the mechanisms involved is associated with bone loss and increase in fragility fractures. This is characteristic of osteoporosis <xref rid="b0005" ref-type="bibr">[1]</xref>. Osteoporosis is most commonly treated with anti-resorptives <xref rid="b0010" ref-type="bibr">[2]</xref>. The only licensed anabolic treatment is intermittent parathyroid hormone (PTH) <xref rid="b0015" ref-type="bibr">[3]</xref> thought to exert its osteogenic effect, at least in part, through down-regulation of the Wnt/bone morphogenetic protein (BMP) antagonist sclerostin <xref rid="b0020" ref-type="bibr">[4]</xref>. Neutralizing antibodies against sclerostin are in clinical trials <xref rid="b0025" ref-type="bibr">[5]</xref>.</p>
      <p>Like PTH, bone loading down-regulates <italic>Sost</italic>/sclerostin expression within osteocytes <xref rid="b0030 b0035 b0040 b0045 b0050" ref-type="bibr">[6–10]</xref>, whereas unloading increases its production <xref rid="b0035 b0055" ref-type="bibr">[7,11]</xref>. Local control of sclerostin could therefore contribute to the mechanism by which loading regulates bone mass. This is consistent with sclerostin knockout mice having high bone mass and being resistant to unloading-induced bone loss <xref rid="b0060" ref-type="bibr">[12]</xref>.</p>
      <p>To elucidate the early mechanisms by which loading regulates sclerostin expression we sought to establish the role of cyclo-oxygenase (Cox)-2/prostaglandin (PG) signaling, which is an early component of bone cells’ response to mechanical strain <xref rid="b0065 b0070 b0075 b0080" ref-type="bibr">[13–16]</xref>.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Choice of cells</title>
        <p>Human osteoblastic Saos2 cells (ECACC Cat. No. 89050205) express a differentiated phenotype <xref rid="b0085" ref-type="bibr">[17]</xref> and have been used to study <italic>Sost</italic> expression <xref rid="b0090" ref-type="bibr">[18]</xref>.</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Reagents and cell culture</title>
        <p>PGE2, AH6809 and AH23848 were from Sigma–Aldrich (Poole, UK). NS398, TCS2510 (TCS), H89, calphostin C, and PD98059 were from Tocris Bioscience (Bristol, UK). Saos2 cells were maintained in phenol red-free DMEM containing 10% heat-inactivated FCS, 2 mM <sc>l</sc>-glutamine, 100 IU/ml penicillin and 100 IU/ml streptomycin in a 37 °C incubator at 5% CO<sub>2</sub>, 95% humidity.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Straining cells in vitro</title>
        <p>Cells were seeded on custom-made plastic strips at an initial density of 40 000 cells/cm<sup>2</sup> in complete medium and allowed to settle for 72 h before serum-deprivation in charcoal–dextran stripped 2% FCS for 24 h prior to strain or treatment. Strain was applied as previously described <xref rid="b0095 b0100" ref-type="bibr">[19,20]</xref> through 600 cycles of four point bending of the strips with a peak strain of 3400 με.</p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)</title>
        <p>qRT-PCR was performed as previously described <xref rid="b0045 b0095 b0100" ref-type="bibr">[9,19,20]</xref>. RNEasy™ Plus Mini Kits (Qiagen, Sussex, UK) were used to eliminate DNA and extract RNA. First strand cDNA synthesis was performed using SuperScriptII™ (Invitrogen, Paisley, UK). Product copy numbers quantified against standard curves were normalized relative to β2-microglobulin. PCR primers were designed using Primer3 Plus <xref rid="b0105" ref-type="bibr">[21]</xref>. Primer sequences (annealing <italic>T</italic><sub>M</sub>) were as follows: <italic>Sost</italic> (60 °C) sense ACTTCAGAGGAGGCAGAAATGG, antisense CAAGGGGGAATCTTATCCAACTTTC; B2MG (60 °C) sense AGCAAGGACTGGTCTTTCTATCTC, antisense CATGTCTCGATCCCACTTAACTATC; EP1 (63 °C) sense CATCCTACTGCGCCAGGCCG, antisense CCAGGCGCTCGGTGTTAGGC; EP2 (60 °C) sense TCGGAACGCTCCGGCTCTCA, antisense AAGCCACTGTCGCGTCTCGC; EP3 (65 °C) sense TCCCAGCAGCGGAGTAGGGC, antisense GCATCCCCTCCGTAGCCCCG; EP4 (62 °C) sense CCTGCAGCACGTCGGATGCT, antisense GGGCCTCTGCTGTGTGCCAA; osteocalcin (65 °C) sense CTTTGTGTCCAAGCAGGAGG, antisense CTGAAAGCCGATGTGGTCAG.</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>Statistical analysis</title>
        <p>Statistical analysis was carried out on SPSSv17 for Windows. Comparison of two groups was by independent samples <italic>t</italic>-tests, more than two groups were by ANOVA with Bonferroni or Games-Howell post hoc adjustments. Data represent pooled results from 2 to 4 independent experiments (each at <italic>n</italic> = 4–6), unless otherwise stated, and are presented as mean ± S.E.M. <italic>P</italic> &lt; 0.05 was considered significant.</p>
      </sec>
    </sec>
    <sec id="s0040">
      <label>3</label>
      <title>Results</title>
      <sec id="s0045">
        <label>3.1</label>
        <title>Strain-induced down-regulation of <italic>Sost</italic> expression involves PG signaling</title>
        <p>Saos2 cells were exposed to strain and harvested at set time-points. In each situation their <italic>Sost</italic> expression was compared to similarly treated control cultures not exposed to strain. Significant <italic>Sost</italic> down-regulation was observed between 8 h and 24 h (reduced to 52 ± 4% and 50 ± 3% of levels in the respective static controls, <italic>P</italic> &lt; 0.001, <xref rid="f0005" ref-type="fig">Fig. 1</xref>A).</p>
        <p>Blockade of Cox-2 with the selective inhibitor NS398 dose-dependently prevented <italic>Sost</italic> down-regulation following strain (30 μM NS398; 96 ± 13%, <italic>P</italic> &gt; 0.05, <xref rid="f0005" ref-type="fig">Fig. 1</xref>B). Exogenous addition of PGE2 dose-dependently (<xref rid="f0005" ref-type="fig">Fig. 1</xref>C) down-regulated <italic>Sost</italic> expression 6 h following treatment (500 nM PGE; 32 ± 3%, <italic>P</italic> &lt; 0.001). Levels remained significantly down-regulated 24 h later (46 ± 5%, <italic>P</italic> &lt; 0.001).</p>
      </sec>
      <sec id="s0050">
        <label>3.2</label>
        <title>PGE2/EP4 signaling is involved in strain-induced <italic>Sost</italic> suppression</title>
        <p>RT-PCR established that Saos2 cells express both EP2 and EP4 receptors. EP1 and EP3 were not detected (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A). Expression of both EP2 and EP4 was increased by strain (200 ± 16% and 212 ± 13%, respectively, <italic>P</italic> &lt; 0.001, <xref rid="f0010" ref-type="fig">Fig. 2</xref>B and C). Blockade of EP2 with 5 μM AH6809 had no significant effect on strain-induced <italic>Sost</italic> down-regulation (50 ± 8%, <italic>P</italic> &lt; 0.001, <xref rid="f0015" ref-type="fig">Fig. 3</xref>A), whereas blockade of EP4 with 5 μM AH23848 prevented its down-regulation by both strain (92 ± 2%, <italic>P</italic> &gt; 0.05, <xref rid="f0015" ref-type="fig">Fig. 3</xref>B) and PGE2 (107% ± 19% 24 h following treatment, <italic>P</italic> &gt; 0.05). Consistent with this result, 2 μM of the selective EP4 agonist TCS <xref rid="b0110" ref-type="bibr">[22]</xref> down-regulated <italic>Sost</italic> expression (46 ± 4%, <italic>P</italic> &lt; 0.01, <xref rid="f0015" ref-type="fig">Fig. 3</xref>C).</p>
        <p>Osteocalcin is another marker of the differentiated phenotype reported to be up-regulated in osteoblastic cells subjected to strain <xref rid="b0115" ref-type="bibr">[23]</xref> or PGE2 <xref rid="b0120" ref-type="bibr">[24]</xref>. Strain-related up-regulation of osteocalcin expression (189 ± 16%, <italic>P</italic> &lt; 0.001) was prevented by blockade of Cox-2 (30 μM NS398; 114 ± 10%, <italic>P</italic> &gt; 0.05) and EP2 (91 ± 08%, <italic>P</italic> &gt; 0.05, <xref rid="f0015" ref-type="fig">Fig. 3</xref>D), but not of EP4 (207 ± 7%, <italic>P</italic> &lt; 0.01, <xref rid="f0015" ref-type="fig">Fig. 3</xref>E). PGE2 up-regulation of osteocalcin (0.5 μM PGE2; 326 ± 32%, <italic>P</italic> &lt; 0.001) was prevented by EP2 blockade (88 ± 15%, <italic>P</italic> &gt; 0.05, <xref rid="f0015" ref-type="fig">Fig. 3</xref>F).</p>
      </sec>
      <sec id="s0055">
        <label>3.3</label>
        <title>Extracellular signal-regulated kinase (ERK) signaling is involved in strain-induced <italic>Sost</italic> down-regulation</title>
        <p>PGE2 signaling is recognized to proceed through protein kinase C (PKC) and protein kinase A (PKA) <xref rid="b0125" ref-type="bibr">[25]</xref>. EP4 has been reported to activate ERK in osteoblastic cells <xref rid="b0125" ref-type="bibr">[25]</xref>. Blockade of PKC with 1 μM photo-activated calphostin C had no significant effect on <italic>Sost</italic> down-regulation (52 ± 8%, <italic>P</italic> &lt; 0.001, <xref rid="f0020" ref-type="fig">Fig. 4</xref>A), but prevented osteocalcin up-regulation (91 ± 8%, <italic>P</italic> &gt; 0.05, <xref rid="f0020" ref-type="fig">Fig. 4</xref>B). Calphostin C also blocked osteocalcin up-regulation with 0.5 μM PGE2 (91 ± 26%, <italic>P</italic> &gt; 0.05, <xref rid="f0020" ref-type="fig">Fig. 4</xref>C). Blockade of PKA with 5 μM H89 prevented neither strain-related osteocalcin up-regulation (216 ± 17%, <italic>P</italic> &lt; 0.001) nor down-regulation of <italic>Sost</italic> by strain or PGE2 (50 ± 7%, <italic>P</italic> &lt; 0.001 and 42 ± 8%, <italic>P</italic> &lt; 0.05, respectively) after 24 h.</p>
        <p>Inhibition of mitogen activated protein kinase (MAPK)/ERK1/2 with 10 μM PD98059 significantly reduced <italic>Sost</italic> levels 8 h after treatment (54 ± 7%, <italic>P</italic> &lt; 0.001) and prevented further strain-induced down-regulation (95 ± 16%, <italic>P</italic> &gt; 0.05 versus PD98059-treated static controls). <italic>Sost</italic> expression in the PD98059-treated static groups was not different from vehicle controls 24 h after treatment (83 ± 8%, <italic>P</italic> &gt; 0.05) and PD98059 again prevented strain-induced <italic>Sost</italic> down-regulation (85 ± 15%, <italic>P</italic> &gt; 0.05, <xref rid="f0020" ref-type="fig">Fig. 4</xref>D), but not osteocalcin up-regulation (268 ± 46%, <italic>P</italic> &lt; 0.05, <xref rid="f0020" ref-type="fig">Fig. 4</xref>E). PD8059 also prevented <italic>Sost</italic> down-regulation by PGE2 24 h following treatment (79 ± 6%, <italic>P</italic> &gt; 0.05, <xref rid="f0020" ref-type="fig">Fig. 4</xref>F).</p>
      </sec>
    </sec>
    <sec id="s0060">
      <label>4</label>
      <title>Discussion</title>
      <p>We demonstrate here that strain-related <italic>Sost</italic> down-regulation in cells of the human osteoblastic Saos2 cell line recapitulates in vitro, in terms of time, that stimulated in osteocytes by loading of the mouse tibia in vivo <xref rid="b0045" ref-type="bibr">[9]</xref>. The time course of <italic>Sost</italic> down-regulation by exposure to a short period of cyclic strain in Saos2 cells differs from that in rat UMR-106 cells exposed to 2 h continuous fluid shear <xref rid="b0130" ref-type="bibr">[26]</xref>. In bone in vivo <italic>Sost</italic> is osteocyte specific, therefore its synthesis (even at low levels <xref rid="b0020" ref-type="bibr">[4]</xref>) by Saos2 cells in vitro is likely to reflect these cells’ differentiated phenotype <xref rid="b0085 b0135" ref-type="bibr">[17,27]</xref>. This contrasts with its supra-physiological expression by UMR-106 cells <xref rid="b0020" ref-type="bibr">[4]</xref>.</p>
      <p>This study also demonstrates that, in Saos2 cells at least, strain-induced <italic>Sost</italic> down-regulation proceeds through Cox-2 mediated PGE2 signaling. This is consistent with the recent report that PGE2 down-regulates <italic>Sost</italic> in UMR-106 cells via an EP2/PKA dependant mechanism <xref rid="b0140" ref-type="bibr">[28]</xref>, whereas here blocking EP2 had no effect on strain-related <italic>Sost</italic> expression. In contrast blockade of EP4 abrogated strain-related <italic>Sost</italic> down-regulation and a specific EP4 agonist down-regulates <italic>Sost</italic> in the absence of either strain or PGE2. This difference between the responses of the Saos2 and UMR-106 cell lines may reflect differences in the cells themselves and/or temporal changes in the mechanism(s) by which <italic>Sost</italic> is regulated. Although one of cells’ major responses to mechanical strain is PGE2 production, the response to strain involves many other mechanisms <xref rid="b0145" ref-type="bibr">[29]</xref>. For instance, strain-related PGE2 release occurs through connexin-43 hemi-channels <xref rid="b0150" ref-type="bibr">[30]</xref> which may result in, and be a response to, activation of many local signaling events in addition to those resulting from a single high dose of PGE2. Nevertheless the involvement of EP4 in strain-related <italic>Sost</italic> regulation is consistent with reports that in vivo an EP4 selective agonist induces bone formation <xref rid="b0155" ref-type="bibr">[31]</xref> and enhances loading-related osteogenesis <xref rid="b0160 b0165" ref-type="bibr">[32,33]</xref>. Mice lacking EP4, but not EP1, EP2 or EP3, are unable to form bone in response to local infusion of PGE2 <xref rid="b0155" ref-type="bibr">[31]</xref>. The effect of EP4 antagonists on loading-related sclerostin down-regulation and osteogenesis now need to be determined in vivo.</p>
      <p>Osteocalcin is also up-regulated following strain by a mechanism involving PGE2 acting through the EP2 receptor. This response was dependent on PKC, whereas <italic>Sost</italic> down-regulation was dependent on ERK. Numerous studies have shown mechanical signals activate ERK <xref rid="b0170 b0175 b0180" ref-type="bibr">[34–36]</xref> but whether ERK then targets Runx2 <xref rid="b0185 b0190" ref-type="bibr">[37,38]</xref>, a major transcriptional regulator of <italic>Sost</italic> <xref rid="b0090" ref-type="bibr">[18]</xref>, remains to be determined.</p>
      <p>These data suggest that short periods of strain stimulate a number of signaling pathways acting on different targets to regulate osteoblastic cell recruitment, proliferation and differentiation. Relieved antagonism of Wnt signaling through <italic>Sost</italic> down-regulation would facilitate proliferation, whereas osteocalcin up-regulation suggests promotion of differentiation. Both processes contribute to the actions and interactions inherent in the functional adaptation of bone mass and architecture. Since these events occur practically simultaneously the targets of the diverse signaling pathways may be different cohorts in the heterogeneous osteoblastic population.</p>
      <p>The data presented here suggests that EP4-selective agonists in pre-clinical testing <xref rid="b0155 b0195" ref-type="bibr">[31,39]</xref> could complement sclerostin-neutralizing therapies as anabolic agents for the effective treatment of osteoporosis while selectively sparing other effects of PGE2 on osteoblastic cells.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Kappa Delta Award paper. Osteoregulatory nature of mechanical stimuli: function as a determinant for adaptive remodeling in bone</article-title>
          <source>J. Orthop. Res.</source>
          <volume>5</volume>
          <year>1987</year>
          <fpage>300</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">3572599</pub-id>
        </element-citation>
      </ref>
      <ref id="b0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baron</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Denosumab and bisphosphonates: different mechanisms of action and effects</article-title>
          <source>Bone</source>
          <volume>48</volume>
          <year>2011</year>
          <fpage>677</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">21145999</pub-id>
        </element-citation>
      </ref>
      <ref id="b0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeve</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Recombinant human parathyroid hormone</article-title>
          <source>BMJ</source>
          <volume>324</volume>
          <year>2002</year>
          <fpage>435</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">11859030</pub-id>
        </element-citation>
      </ref>
      <ref id="b0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kneissel</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>SOST is a target gene for PTH in bone</article-title>
          <source>Bone</source>
          <volume>37</volume>
          <year>2005</year>
          <fpage>148</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">15946907</pub-id>
        </element-citation>
      </ref>
      <ref id="b0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Padhi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stouch</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Posvar</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody</article-title>
          <source>J. Bone Miner. Res.</source>
          <volume>26</volume>
          <year>2011</year>
          <fpage>19</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">20593411</pub-id>
        </element-citation>
      </ref>
      <ref id="b0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callewaert</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schrooten</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Van Meerbeek</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Verhoeven</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Boonen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vanderschueren</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Androgen receptor disruption increases the osteogenic response to mechanical loading in male mice</article-title>
          <source>J. Bone Miner. Res.</source>
          <volume>25</volume>
          <year>2010</year>
          <fpage>124</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">19821763</pub-id>
        </element-citation>
      </ref>
      <ref id="b0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robling</surname>
              <given-names>A.G.</given-names>
            </name>
          </person-group>
          <article-title>Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>5866</fpage>
          <lpage>5875</lpage>
          <pub-id pub-id-type="pmid">18089564</pub-id>
        </element-citation>
      </ref>
      <ref id="b0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moustafa</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading</article-title>
          <source>Bone</source>
          <volume>44</volume>
          <year>2009</year>
          <fpage>930</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="pmid">19442626</pub-id>
        </element-citation>
      </ref>
      <ref id="b0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Saxon</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Sunters</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hilton</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Underhill</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disuse</article-title>
          <source>Bone</source>
          <volume>46</volume>
          <year>2010</year>
          <fpage>628</fpage>
          <lpage>642</lpage>
          <pub-id pub-id-type="pmid">19857613</pub-id>
        </element-citation>
      </ref>
      <ref id="b0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonnet</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Standley</surname>
              <given-names>K.N.</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Stadelmann</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Foti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>35939</fpage>
          <lpage>35950</lpage>
          <pub-id pub-id-type="pmid">19837663</pub-id>
        </element-citation>
      </ref>
      <ref id="b0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaudio</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss</article-title>
          <source>J. Clin. Endocrinol. Metab.</source>
          <volume>95</volume>
          <year>2010</year>
          <fpage>2248</fpage>
          <lpage>2253</lpage>
          <pub-id pub-id-type="pmid">20305005</pub-id>
        </element-citation>
      </ref>
      <ref id="b0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling</article-title>
          <source>J. Bone Miner. Res.</source>
          <volume>24</volume>
          <year>2009</year>
          <fpage>1651</fpage>
          <lpage>1661</lpage>
          <pub-id pub-id-type="pmid">19419300</pub-id>
        </element-citation>
      </ref>
      <ref id="b0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Burr</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <article-title>Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading</article-title>
          <source>Calcif. Tissue Int.</source>
          <volume>70</volume>
          <year>2002</year>
          <fpage>320</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">12004337</pub-id>
        </element-citation>
      </ref>
      <ref id="b0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pead</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Indomethacin modulation of load-related stimulation of new bone formation in vivo</article-title>
          <source>Calcif. Tissue Int.</source>
          <volume>45</volume>
          <year>1989</year>
          <fpage>34</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">2504461</pub-id>
        </element-citation>
      </ref>
      <ref id="b0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chow</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation</article-title>
          <source>Am. J. Physiol.</source>
          <volume>267</volume>
          <year>1994</year>
          <fpage>E287</fpage>
          <lpage>E292</lpage>
          <pub-id pub-id-type="pmid">8074209</pub-id>
        </element-citation>
      </ref>
      <ref id="b0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forwood</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo</article-title>
          <source>J. Bone Miner. Res.</source>
          <volume>11</volume>
          <year>1996</year>
          <fpage>1688</fpage>
          <lpage>1693</lpage>
          <pub-id pub-id-type="pmid">8915776</pub-id>
        </element-citation>
      </ref>
      <ref id="b0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Peruzzi</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Fortunati</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>De Luca</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Denger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Caselli</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Migliaccio</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Teti</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells</article-title>
          <source>J. Mol. Endocrinol.</source>
          <volume>37</volume>
          <year>2006</year>
          <fpage>489</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="pmid">17170089</pub-id>
        </element-citation>
      </ref>
      <ref id="b0090">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sevetson</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST)</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>13849</fpage>
          <lpage>13858</lpage>
          <pub-id pub-id-type="pmid">14739291</pub-id>
        </element-citation>
      </ref>
      <ref id="b0095">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armstrong</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Muzylak</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sunters</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zaman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Saxon</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>20715</fpage>
          <lpage>20727</lpage>
          <pub-id pub-id-type="pmid">17491024</pub-id>
        </element-citation>
      </ref>
      <ref id="b0100">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunters</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Zaman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kypta</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling</article-title>
          <source>J. Biol. Chem.</source>
          <volume>285</volume>
          <year>2010</year>
          <fpage>8743</fpage>
          <lpage>8758</lpage>
          <pub-id pub-id-type="pmid">20042609</pub-id>
        </element-citation>
      </ref>
      <ref id="b0105">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Skaletsky</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Primer3 on the WWW for general users and for biologist programmers</article-title>
          <source>Methods Mol. Biol.</source>
          <volume>132</volume>
          <year>2000</year>
          <fpage>365</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">10547847</pub-id>
        </element-citation>
      </ref>
      <ref id="b0110">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Billot</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Discovery of a potent and selective agonist of the prostaglandin EP4 receptor</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <volume>13</volume>
          <year>2003</year>
          <fpage>1129</fpage>
          <lpage>1132</lpage>
          <pub-id pub-id-type="pmid">12643927</pub-id>
        </element-citation>
      </ref>
      <ref id="b0115">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shimokawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kanno</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ohya</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Soma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Effects of mechanical strain on proliferation and differentiation of bone marrow stromal cell line ST2</article-title>
          <source>J. Bone Miner. Metab.</source>
          <volume>23</volume>
          <year>2005</year>
          <fpage>219</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">15838624</pub-id>
        </element-citation>
      </ref>
      <ref id="b0120">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhary</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Alander</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Pilbeam</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Raisz</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist</article-title>
          <source>Prostaglandins Other Lipid Mediat.</source>
          <volume>86</volume>
          <year>2008</year>
          <fpage>35</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">18406186</pub-id>
        </element-citation>
      </ref>
      <ref id="b0125">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minamizaki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yoshiko</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kozai</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Aubin</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures</article-title>
          <source>Bone</source>
          <volume>44</volume>
          <year>2009</year>
          <fpage>1177</fpage>
          <lpage>1185</lpage>
          <pub-id pub-id-type="pmid">19233324</pub-id>
        </element-citation>
      </ref>
      <ref id="b0130">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papanicolaou</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Phipps</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Fyhrie</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Genetos</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells</article-title>
          <source>Biorheology</source>
          <volume>46</volume>
          <year>2009</year>
          <fpage>389</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="pmid">19940355</pub-id>
        </element-citation>
      </ref>
      <ref id="b0135">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orimo</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells</article-title>
          <source>Mol. Cell. Biochem.</source>
          <volume>315</volume>
          <year>2008</year>
          <fpage>51</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">18500657</pub-id>
        </element-citation>
      </ref>
      <ref id="b0140">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Genetos</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Yellowley</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Loots</surname>
              <given-names>G.G.</given-names>
            </name>
          </person-group>
          <article-title>Prostaglandin E(2) signals through PTGER2 to regulate sclerostin expression</article-title>
          <source>PLoS ONE</source>
          <volume>6</volume>
          <year>2011</year>
          <fpage>e17772</fpage>
          <pub-id pub-id-type="pmid">21436889</pub-id>
        </element-citation>
      </ref>
      <ref id="b0145">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Price</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Galea</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Meakin</surname>
              <given-names>L.B.</given-names>
            </name>
            <name>
              <surname>Sunters</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading</article-title>
          <source>Curr. Osteoporos. Rep.</source>
          <volume>9</volume>
          <year>2011</year>
          <fpage>76</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">21384138</pub-id>
        </element-citation>
      </ref>
      <ref id="b0150">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cherian</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Siller-Jackson</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Bonewald</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Sprague</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>J.X.</given-names>
            </name>
          </person-group>
          <article-title>Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin</article-title>
          <source>Mol. Biol. Cell</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>3100</fpage>
          <lpage>3106</lpage>
          <pub-id pub-id-type="pmid">15843434</pub-id>
        </element-citation>
      </ref>
      <ref id="b0155">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>99</volume>
          <year>2002</year>
          <fpage>4580</fpage>
          <lpage>4585</lpage>
          <pub-id pub-id-type="pmid">11917107</pub-id>
        </element-citation>
      </ref>
      <ref id="b0160">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Baik</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Soma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Bone formation and tooth movement are synergistically enhanced by administration of EP4 agonist</article-title>
          <source>Am. J. Orthod. Dentofacial Orthop.</source>
          <volume>132</volume>
          <year>2007</year>
          <comment>427.e13–e20</comment>
        </element-citation>
      </ref>
      <ref id="b0165">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagino</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kuraoka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kameyama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Teshima</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading</article-title>
          <source>Bone</source>
          <volume>36</volume>
          <year>2005</year>
          <fpage>444</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="pmid">15777678</pub-id>
        </element-citation>
      </ref>
      <ref id="b0170">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jessop</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Rawlinson</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Pitsillides</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Mechanical strain and fluid movement both activate extracellular regulated kinase (ERK) in osteoblast-like cells but via different signaling pathways</article-title>
          <source>Bone</source>
          <volume>31</volume>
          <year>2002</year>
          <fpage>186</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">12110433</pub-id>
        </element-citation>
      </ref>
      <ref id="b0175">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jessop</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Sjoberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>M.Z.</given-names>
            </name>
            <name>
              <surname>Zaman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wheeler-Jones</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>L.E.</given-names>
            </name>
          </person-group>
          <article-title>Mechanical strain and estrogen activate estrogen receptor alpha in bone cells</article-title>
          <source>J. Bone Miner. Res.</source>
          <volume>16</volume>
          <year>2001</year>
          <fpage>1045</fpage>
          <lpage>1055</lpage>
          <pub-id pub-id-type="pmid">11393781</pub-id>
        </element-citation>
      </ref>
      <ref id="b0180">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Early responses of osteoblast-like cells to different mechanical signals through various signaling pathways</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>348</volume>
          <year>2006</year>
          <fpage>1167</fpage>
          <lpage>1173</lpage>
          <pub-id pub-id-type="pmid">16904072</pub-id>
        </element-citation>
      </ref>
      <ref id="b0185">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Harimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hinshaw</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Spata4 promotes osteoblast differentiation through Erk-activated Runx2 pathway</article-title>
          <source>J. Bone Miner. Res.</source>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="b0190">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ge</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Hatch</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Roca</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Franceschi</surname>
              <given-names>R.T.</given-names>
            </name>
          </person-group>
          <article-title>Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>32533</fpage>
          <lpage>32543</lpage>
          <pub-id pub-id-type="pmid">19801668</pub-id>
        </element-citation>
      </ref>
      <ref id="b0195">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Konaka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats</article-title>
          <source>Bone</source>
          <volume>39</volume>
          <year>2006</year>
          <fpage>453</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">16581323</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by Wellcome Trust Training Fellowships for Veterinarians (G.L.G. and L.B.M.) and a Wellcome Trust Programme Grant (L.E.L. and J.S.P.).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>Strain-induced <italic>Sost</italic> down-regulation involves Cox-2/PG signaling. (A) Saos2 cells were subjected to strain and harvested at the indicated time points with static controls. (B) Cells were pre-treated for 30 min with the indicated doses of NS398 before strain and harvested 8 h later with static controls. (C) Cells were treated with vehicle or the indicated doses of PGE2 and harvested 6 h later. <italic>Sost</italic> levels were quantified by qRT-PCR. Representative experiments shown, <italic>n</italic> = 6. NS, not significant; <sup>∗</sup><italic>P</italic> &lt; 0.05; <sup>∗∗</sup><italic>P</italic> &lt; 0.01; <sup>∗∗∗</sup><italic>P</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Expression of EP2 and EP4 receptors. (A) Non-exon-spanning primers were used to amplify EP1–4 in cDNA or gDNA positive controls from Saos2 cells. Products were visualized by agarose gel electrophoresis with no RT or no gDNA controls. A representative gel is shown. (B, C) Cells were exposed to strain and harvested 24 h later with static controls. (B) EP2 and (C) EP4 levels were quantified by qRT-PCR. <sup>∗∗∗</sup><italic>P</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Strain-induced <italic>Sost</italic> down-regulation involves EP4 signaling. Saos2 cells were pre-treated for 30 min with (A, D) 5 μM AH6809 or (B, E) 5 μM AH23848 before exposure to strain and harvested 24 h later. (C) Cells were treated with 2 μM TCS and harvested 6 h later. (F) Cells were treated with AH6809 30 min before treatment with 0.5 μM PGE2 and harvested 6 h later. (A, B, C) <italic>Sost</italic> and (D, E, F) osteocalcin levels were quantified by qRT-PCR. NS, not significant; <sup>∗</sup><italic>P</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>P</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>Strain-induced <italic>Sost</italic> down-regulation involves ERK signaling. (A, B) Saos2 cells were treated with 1 μM calphostin C 30 min before strain and harvested 24 h later. (C) Cells were treated with 1 μM calphostin C 30 min before treatment with 0.5 μM PGE2 and harvested 6 h later. (D, E) Cells were treated with 10 μM PD98059 30 min before strain and harvested 24 h later. (F) Cells were treated with 10 μM PD98059 30 min before treatment with 0.5 μM PGE2 and harvested 24 h later. (A, D, F) <italic>Sost</italic> and (B, C, E) osteocalcin levels were quantified by qRT-PCR. NS, not significant; <sup>∗</sup><italic>P</italic> &lt; 0.05; <sup>∗∗∗</sup><italic>P</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>